Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
 
Special Report
Govt actions make patent defence riskier
The decision to pursue a patent infringement case is becoming more problematic in the face of hefty government compensation claims inflicted when defences fail.
Open Forum
Time to support biosimilars
Biosimilars will play an important role in the PBS system and industry needs to support an evidence-based role for these medicines, rather than seeking to restrict their uptake says regulatory expert.
Pipeline Monitor
AZ scores cancer win, lays out more pipeline
Lung cancer drug Tagrisso has been given the go-ahead in Europe while four new treatments are on the way to filing says pharma giant AZ.
Working Life
Networking: how to do it better
Love it or hate it, networking is an essential part of many jobs. The good news is, if you find it awkward, it's not so hard to improve.
Approvals Action
New registrations in asthma and cholesterol
The TGA has granted registration for GSK's new asthma biological and for another wave of cholesterol lowering generics.